BRAF and neoplasm: Since 3635PXA patient tumor contained 13% normal diploid cells, the corrected BRAF V600E mutation rate increased from 28% to 32.18% (i.e., 28/87=32.18%), it is still much lower than that in the xenograft tumors (>67%).